We selected a panel of breast cancer cell lines comprising three major subtypes of breast cancer: ER+ (ZR-75-1), HER2+ (SKBR3), and triple-negative (HCC-38, MDA-MB-231, BT-20). This evidence concerns the gene ERBB2 and hepatocellular carcinoma.